Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06980493
PHASE2/PHASE3

Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if topical amphotericin b solution works to treat resistant cases of tinea capitis in children. It will also learn about the safety of drug. The main questions it aims to answer are: Does amphotericin b solution effective in cases not cured by systemic antifungal tab? Participants will: use topical amphotericin b solution every day for8 weeks Visit the clinic once every 1 week for follow up then follow up after 1 month and fungal culture will be done to test if the treatment working

Official title: Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis

Key Details

Gender

All

Age Range

0 Days - 16 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-04-01

Completion Date

2025-08-01

Last Updated

2025-05-20

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Amphotericine in liposome (Ambisome®)

The aim of the study will be to evaluate the efficacy and safety of topical amphotericin B solution in treatment of non-inflammatory type of tinea capitis after resistant response to oral systemic treatment

Locations (1)

Sohag faculty of medicine

Sohag, Egypt